MFDS — authorised 19 August 1974
- Marketing authorisation holder: APOTHECON
- Status: likely_approved
🇰🇷 Cefradex in South Korea
MFDS authorised Cefradex on 19 August 1974
Marketing authorisation
Cefradex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Cefradex approved in South Korea?
Yes. MFDS authorised it on 19 August 1974.
Who is the marketing authorisation holder for Cefradex in South Korea?
APOTHECON holds the South Korean marketing authorisation.